Skip to content

Ayurvedic management of Switra (Vitiligo) in children

Clinical study to evaluate the combined effect of Harataladi lepa and Bakuchi churna capsule in the management of Switra (Vitiligo) in children

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/042983
Enrollment
30
Registered
2022-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The children of either gender between the age group of 6-16 years fulfilling the diagnostic criteria of Vitiligo. 2. Children, whose parents are willing to participate them in the study after giving informed parent consent.

Exclusion criteria

Exclusion criteria: 1. Vitiligo patches developed as a complication of burns. 2. Children diagnosed with autoimmune disorders, neurological disorders, endocrine disorders, leprosy and tuberculosis. 3. Children with universal vitiligo and mucosal vitiligo.

Design outcomes

Primary

MeasureTime frame
The increase in pigmentation of Vitiligo patches will be measured before ad after interventionTimepoint: 30 days

Secondary

MeasureTime frame
Reduction in the size of Vitiligo patchesTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Arun Raj GR

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan

drdrarunraj26@gmail.com9886292826

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026